Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma
Recruiting now · Not applicable
Conditions studied: Glaucoma Open-Angle
In brief
The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are: * Can both devices produce similar results in terms of detecting visual field defects and progression? * Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices? Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.
Key facts
- Study ID
- NCT07063537
- Run by
- Nova Scotia Health Authority
- People needed
- 60
- Starts
- 2024-12-14
- Expected to finish
- 2025-10-01
- Last updated by the study team
- 2025-07-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- >18 years of age
- diagnosis of primary open-angle glaucoma
- ability to perform visual field testing
- capacity to provide informed consent to research protocol
You may not qualify if…
- diagnosis of secondary glaucoma or non-glaucomatous optic neuropathy
- previous intraocular surgery (excluding cataract surgery and minimally invasive glaucoma surgery)
- significant media opacity
- pregnancy
- seizure disorder
- cardiac pacemaker/other implantable device
- severe vertigo/balance disorder
Where it is running
- Eadie Technologies Inc — Halifax, Nova Scotia, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.